Strengthen the global collaboration network on R&D: Pharma secretary at G20
Pharma secretary S. Aparna stated that the discussions have helped to define the pathway for collaborative partnerships and provided us with a framework to envision the global R&D network
PremiumNew Delhi: The union pharma secretary S Aparna on Tuesday said that initiatives like global research & development network can collectively build a future where access to life-saving medical countermeasures becomes a universal reality.
Aparna delivered the closing remarks at the concluding session of the 3rd G20 Health Working Group Meeting here at Hyderabad where members of G20 countries participated to discuss contribution in strengthening the pharma sector.
Day 3 of the HWG meeting also witnessed a panel discussion on “Envisaging a Global R&D Network for Research in VTDs to enhance PPR.
She stated that “the discussions have helped to define the pathway for collaborative partnerships and provided us with a framework to envision the global R&D network.
“The discussions have helped to define the pathway for collaborative partnerships and provided us with a framework to envision the global R&D network. The time is now to build collaboration among nations, institutions, and stakeholders through a global R&D network that fosters innovation and accelerates research. This would be a necessary element to build the requisite agility and bench strength on a global scale to predict, prepare for and respond to future health emergencies in a robust, equitable and timely manner".
She emphasized on “the power of collective action and partnerships in expediting research and development, as a necessary precursor to equitable distribution, and access to life-saving medical countermeasures against epidemic and endemic diseases." “The timely deployment of appropriate countermeasures in an emergency, also relies to a large extent, on those having been developed and tested by continuous interaction with a variety of stakeholders in different locations and socio-economic situations during peace time", she further stated.
On the structure of such a mechanism, Aparna stated that “a Network of Networks which encouraging regional and local cooperation as well as greater alignment of existing partnerships and principles such as those found in World Health Organization (WHO) Blueprint for epidemics and the 100 days Mission would be an efficient and effective path towards Impact driven Collaboration".
“That such a collaboration on R&D should factor in a globally accessible database covering priority pathogens, ongoing research on vaccines, therapeutics and diagnostics (VTDs), and development of disease agnostic technologies would help to address challenges such as the asymmetry of information, the lack of availability of critical materials, low attention to certain products needed by small patient populations as well as the inequitable access to potential solutions that currently obtains across geographies and communities", she stated.
"Exciting news! Mint is now on WhatsApp Channels 🚀 Subscribe today by clicking the link and stay updated with the latest financial insights!" Click here!
